LifeMD, Inc. (LFMDP)
USD 23.4
(1.12%)
USD 23.4
(1.12%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -14.21 Million USD | -8534.73% |
| 2022 | 168.52 Thousand USD | 100.43% |
| 2021 | -39.47 Million USD | -386.51% |
| 2020 | -8.11 Million USD | -2998.22% |
| 2019 | -261.91 Thousand USD | -489.04% |
| 2018 | 67.32 Thousand USD | 157.94% |
| 2017 | 26.1 Thousand USD | 9.65% |
| 2016 | 23.8 Thousand USD | 117.9% |
| 2015 | -132.98 Thousand USD | -175.36% |
| 2014 | -48.29 Thousand USD | 57.95% |
| 2013 | -114.85 Thousand USD | -16.1% |
| 2012 | -98.93 Thousand USD | -143.26% |
| 2011 | 228.67 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -14.88 Million USD | 2.1% |
| 2024 Q1 | -15.2 Million USD | -6.99% |
| 2023 Q1 | 4.95 Million USD | 2837.64% |
| 2023 Q4 | -14.21 Million USD | -392.43% |
| 2023 Q2 | 3.4 Million USD | -31.27% |
| 2023 Q3 | 4.86 Million USD | 42.86% |
| 2023 FY | -14.21 Million USD | -8534.73% |
| 2022 Q3 | -4.42 Million USD | 56.33% |
| 2022 Q2 | -10.14 Million USD | 56.44% |
| 2022 Q1 | -23.28 Million USD | 41.03% |
| 2022 FY | 168.52 Thousand USD | 100.43% |
| 2022 Q4 | 168.52 Thousand USD | 103.81% |
| 2021 FY | -39.47 Million USD | -386.51% |
| 2021 Q3 | 1.65 Million USD | 122.09% |
| 2021 Q4 | -39.47 Million USD | -2488.02% |
| 2021 Q2 | -7.48 Million USD | 39.98% |
| 2021 Q1 | -12.46 Million USD | -53.66% |
| 2020 Q3 | 865.74 Thousand USD | 13.36% |
| 2020 FY | -8.11 Million USD | -2998.22% |
| 2020 Q1 | 272.01 Thousand USD | 203.86% |
| 2020 Q2 | 763.71 Thousand USD | 180.76% |
| 2020 Q4 | -8.11 Million USD | -1037.3% |
| 2019 Q2 | 35.27 Thousand USD | -83.74% |
| 2019 Q1 | 217.02 Thousand USD | 222.36% |
| 2019 Q4 | -261.91 Thousand USD | -826.53% |
| 2019 FY | -261.91 Thousand USD | -489.04% |
| 2019 Q3 | -28.26 Thousand USD | -180.13% |
| 2018 Q3 | -407.27 Thousand USD | 35.16% |
| 2018 FY | 67.32 Thousand USD | 157.94% |
| 2018 Q4 | 67.32 Thousand USD | 116.53% |
| 2018 Q2 | -628.07 Thousand USD | -173.28% |
| 2018 Q1 | -229.82 Thousand USD | -980.57% |
| 2017 Q1 | -356.05 Thousand USD | -1595.78% |
| 2017 Q2 | -362.04 Thousand USD | -1.68% |
| 2017 Q3 | -485.42 Thousand USD | -34.08% |
| 2017 Q4 | 26.1 Thousand USD | 105.38% |
| 2017 FY | 26.1 Thousand USD | 9.65% |
| 2016 Q3 | -259.8 Thousand USD | -91.81% |
| 2016 FY | 23.8 Thousand USD | 117.9% |
| 2016 Q1 | -103.62 Thousand USD | 22.08% |
| 2016 Q2 | -135.45 Thousand USD | -30.72% |
| 2016 Q4 | 23.8 Thousand USD | 109.16% |
| 2015 Q2 | 18.93 Thousand USD | -13.49% |
| 2015 Q4 | -132.98 Thousand USD | -507.73% |
| 2015 Q3 | 32.61 Thousand USD | 72.23% |
| 2015 Q1 | 21.89 Thousand USD | 145.33% |
| 2015 FY | -132.98 Thousand USD | -175.36% |
| 2014 Q2 | -37.94 Thousand USD | -362.26% |
| 2014 Q1 | -8209.00 USD | 92.85% |
| 2014 Q4 | -48.29 Thousand USD | -111.78% |
| 2014 Q3 | -22.8 Thousand USD | 39.91% |
| 2014 FY | -48.29 Thousand USD | 57.95% |
| 2013 Q2 | -111.05 Thousand USD | -185.37% |
| 2013 Q1 | -38.91 Thousand USD | 60.66% |
| 2013 FY | -114.85 Thousand USD | -16.1% |
| 2013 Q4 | -114.85 Thousand USD | -215.09% |
| 2013 Q3 | -36.45 Thousand USD | 67.18% |
| 2012 Q3 | -163.18 Thousand USD | 0.0% |
| 2012 FY | -98.93 Thousand USD | -143.26% |
| 2012 Q4 | -98.93 Thousand USD | 39.37% |
| 2011 FY | 228.67 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| CannBioRx Life Sciences Corp. | -655.73 Thousand USD | -2067.717% |
| BIMI International Medical Inc. | 3.11 Million USD | 555.778% |
| China Jo-Jo Drugstores, Inc. | 10.34 Million USD | 237.393% |
| Harrow Health, Inc. 8.625% Senior Notes due 2026 | 116.41 Million USD | 112.21% |
| Harrow Health, Inc. 11.875% Senior Notes due 2027 | 109.08 Million USD | 113.03% |
| Leafly Holdings, Inc. | 13.79 Million USD | 203.062% |
| Leafly Holdings, Inc. | 13.79 Million USD | 203.062% |
| LifeMD, Inc. | -14.21 Million USD | -0.0% |
| TRxADE HEALTH, Inc. | 6.95 Million USD | 304.464% |
| PetMed Express, Inc. | -53.84 Million USD | 73.6% |
| Walgreens Boots Alliance, Inc. | 8.23 Billion USD | 100.173% |